Compelling indications in JNC7 that warrant β-blocker therapy include heart failure with reduced ejection fraction (HFrEF)2,3, acute myocardial infarction (AMI)4, high coronary disease risk, and diabetes. While there is...
Read MoreDoes insulin worsen cardiovascular outcomes and cause cancer? Should insulin be reserved as the last resort? In 2008, ACCORD raised questions about the cardiovascular safety of insulin, at least in patients with type 2...
Read MoreThe biggest superstar in the dietary supplement industry is fish oil. It is available over-the-counter and you can even buy orange juice fortified with it. Unfortunately, most of these products contain very low amounts of...
Read MoreThe Patient Protection and Affordable Care Act (PPACA but often called the ACA) was signed into law by President Barack Obama on March 23, 2010 after it passed both the House and Senate following 2 years of debate in Congress....
Read MoreBlood pressure is known to follow a circadian rhythm in which the blood pressure falls by approximately 10% overnight.1 In many patients with hypertension (HTN) this drop in nocturnal blood pressure is blunted....
Read MoreDronedarone (Multaq®), a guideline recommended drug therapy option for paroxysmal and persistent atrial fibrillation (AF), has failed to deliver on the initial hopes and hype as the safer alternative to...
Read MoreThe American College of Chest Physicians Antithrombotic Guidelines, 9th edition are now available. Here’s a short summary about what every clinician should know. 2. The Patient’s Opinion...
Read More“See you in four weeks!” This has been a common ending to most anticoagulation clinic appointments over the years. But perhaps it’s time for this routine to change? A welcomed 12-week holiday may be coming for many...
Read More
iForumRx.org is a web-based community of practice designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high-quality, practice-changing evidence.
Loading ...